ImmunityBio, Inc. (IBRX)
7.76
-0.24
(-3.00%)
USD |
NASDAQ |
May 19, 16:00
7.99
+0.23
(+2.96%)
After-Hours: 20:00
ImmunityBio Shareholders Equity (Quarterly) : -870.01M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Atara Biotherapeutics, Inc. | -37.31M |
| Gilead Sciences, Inc. | 23.52B |
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| Neurocrine Biosciences, Inc. | 3.407B |
| Iovance Biotherapeutics, Inc. | 721.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 646.64M |
| Total Liabilities (Quarterly) | 1.516B |
| Debt to Equity Ratio | -1.293 |
| Current Ratio | 6.666 |
| Net Debt Paydown Yield | -0.83% |